Giới Thiệu Công Ty
- Tên pháp lý: Transo-Pharm Handels GmbH
- Quốc gia đăng ký: Germany
- Địa chỉ: Bueltbek 5, 22962 Siek
- Số nhân viên: 25 - 49
Mô tả:
Transo-Pharm, founded in 1987, is a fully licensed global distributor of pharmaceutical components for health and veterinary industries. It supports customers throughout the API lifecycle, from development to sales, offering diverse products and qualifying manufacturers for compliance. Acting as a sourcing and regulatory marketing agent, Transo-Pharm has offices in Shanghai, Hong Kong, Singapore, the United States, and an affiliated office in Mumbai. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Hoạt Động Kinh Doanh
Nguyên liệu Dược phẩm (API)
Nhà Phân PhốiĐơn Vị LogisticsTư Vấn Pháp Chế Đăng Ký
Phân loại ATC (Giải phẫu - Điều trị - Hóa học)
Nhà Phân PhốiĐơn Vị LogisticsTư Vấn Pháp Chế Đăng Ký
API Biệt dược Gốc
Nhà Phân PhốiĐơn Vị LogisticsTư Vấn Pháp Chế Đăng Ký
Dịch vụ Pháp chế Dược & Nghiên cứu Thị trường
Nhà Cung Cấp Dịch Vụ
Sản Phẩm/Dịch Vụ Chính
- Nguyên liệu Dược phẩm (API): Hyoscine N-Butylbromide (CEP), Ajmaline (ASMF), Noscapine (ASMF), Scopolamine Hydrobromide (CEP / US-DMF), Scopolamine Methylbromide (US-DMF), Doxorubicin HCl (CEP), Epirubicin HCl ( CEP / US-DMF), Idarubicin HCl (ASMF / US-DMF), Nelarabine (US-DMF), Valrubicin (US-DMF), Epinephrine Base (CEP / US-DMF), Epinephrine Bitartrate (CEP / US-DMF), Estriol (CEP), Norepinephrine bitartrate (CEP / US-DMF), Thyroid Extract (USP), Dorzolamide HCl (CEP), Acetylcysteine (CEP), Crotamiton (CEP / US-DMF), Dexmedetomidine (ASMF), Guaifenesin (CEP / US-DMF), Hyoscine (CEP), Levosimendan (ASMF), Methocarbamol (ASMF / US-DMF), Nonivamide (ASMF), Phenylephrine HCl (CEP / US-DMF), Tranexamic Acid (CEP)
- API Biệt dược Gốc: Digoxin (CEP / US-DMF)
- Dược phẩm Thú y & Phụ gia Thức ăn Chăn nuôi: Clenbuterol HCl (CEP / US-VMF)
Sản Phẩm & Dịch Vụ Của Chúng Tôi
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Chứng nhận
Chứng Nhận CEP
DMF
GMP
Bằng chứng
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Đánh giá
(0)
(0)
(0)
(0)
(0)
Bình luận
Lọc:
Sắp xếp theo:
Chưa có bình luận nào.
Để lại đánh giá & nhận xét